Skip to main content
. 2016 Feb 3;11(2):e0148463. doi: 10.1371/journal.pone.0148463

Fig 2. Difference in EORTC-QLQ C30 scores at baseline and follow-up and compared with a Danish reference group and a cancer reference group.

Fig 2